این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
دوشنبه 17 شهریور 1404
International Journal of Pediatrics
، جلد ۴، شماره ۷، صفحات ۲۲۲۱-۲۲۲۸
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Comparing the Outcomes of IVIg with Combination of IVIg and Methylprednisolone in Children with Acute Idiopathic Thrombocytopenia; a Bayesian Logistic Approach
چکیده انگلیسی مقاله
Background This study aimed to evaluate the effectiveness of Intravenous immunoglobulin (IVIg) and combination of IVIg and Methylprednisolone for childhood Idiopathic (autoimmune) Thrombocytopenia (ITP) treatment; in addition investigate the related factors to develop chronic form of under 15 years ITP. Materials and Methods This retrospective study conducted on 88 ITP patients that treated with IVIg or combination of IVIg and Methylpredinosolon. Children were treated with IVIg 2 mg/kg/d or combination of IVIg 2 mg/kg/d and Methylpredinosolon20 mg/kg/dfor maximum 5 days. The numbers of patients with a platelet count > 50,000/μl, after treatment initiation, were the primary outcome. Odds Ratio (OR) as well as 95% Bayesian Credible interval (Crl), were estimated using a Bayesian Logistic regression model. Results The median age of subjects was 3.5+ 4.42 years (Interquartile: 2 8.5). About 13% of patients were discharged from hospitalization in day 2 and day 3. The ITP of 23% of children were progressed to chronic form. The following factors were significantly associated with the development of chronic ITP, combination of IVIg and Methylprednisolone [OR: 3.24, 95% Crl: [1.06 11.11]), and day 2 and 3 of discharge from hospitalization (OR: 7.72, 95% Crl: (1.14 67.16)]. Conclusion The current results, suggest that the both IVIg and combination of IVIg are equally effective in providing a platelet level > 50,000/μl early. In addition patients how received combination drug were more likely to develop to chronic ITP. Therefore, we suggest that this route must be preferentially used in decision making for treatment childhood ITP.
کلیدواژههای انگلیسی مقاله
نویسندگان مقاله
سید کمال اسحاق حسینی | seyed kamal eshagh hoseini
assistant professor, pediatric hematology research center, faculty of medicine, qom university of medical sciences, qom, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی قم (Qom university of medical sciences)
شهرام ارسنگ جنگ | shahram arsang jang
phd candidate of biostatistics, health policy and promotion research center, qom university of medical sciences, qom, iran
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی قم (Qom university of medical sciences)
توحید جعفری کشکی | tohid jafari koshki
3phd candidate of biostatistics, department of biostatistics and epidemiology, kermanshah university of medical sciences, kermanshah, iran.
سازمان اصلی تایید شده
: دانشگاه علوم پزشکی کرمانشاه (Kermanshah university of medical sciences)
نشانی اینترنتی
http://ijp.mums.ac.ir/article_7096.html
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات